X

Trial Profile

A Prospective , Multicenter, Randomized Phase III Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients.

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
Indications Diffuse large B cell lymphoma
Focus Therapeutic Use

Most Recent Events

11 Dec 2015 Biomarkers information updated
14 Feb 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01793844).
21 May 2012 Planned end date (31 Dec 2017) added as reported by Chinese Clinical Trial Register record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com